Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications
Patient-Reported Outcomes in RLBP1 Retinal Dystrophy: Longitudinal Assessment in a Prospective Natural History Study.
Journal: Translational vision science & technology
Published: November 14, 2024
Multiparametric grading of glaucoma severity by histopathology can enable post-mortem substratification of disease state.
Journal: Acta neuropathologica communications
Published: May 29, 2024
Interim safety and efficacy of gene therapy for RLBP1-associated retinal dystrophy: a phase 1/2 trial.
Journal: Nature communications
Published: March 26, 2024
Retinal Dystrophy Associated With RLBP1 Retinitis Pigmentosa: A Five-Year Prospective Natural History Study.
Journal: Investigative ophthalmology & visual science
Published: October 26, 2023
Anti-brolucizumab immune response as one prerequisite for rare retinal vasculitis/retinal vascular occlusion adverse events.
Journal: Science translational medicine
Published: February 01, 2023
A root cause analysis to identify the mechanistic drivers of immunogenicity against the anti-VEGF biotherapeutic brolucizumab.
Journal: Science translational medicine
Published: February 01, 2023
Complement factor B is critical for sub-RPE deposit accumulation in a model of Doyne honeycomb retinal dystrophy with features of age-related macular degeneration.
Journal: Human molecular genetics
Published: June 15, 2022
A Randomized, Double-Masked, Multicenter Trial of Topical Acrizanib (LHA510), a Tyrosine Kinase VEGF-Receptor Inhibitor, in Treatment-Experienced Subjects With Neovascular Age-Related Macular Degeneration.
Journal: American journal of ophthalmology
Published: September 29, 2021
A proteogenomic signature of age-related macular degeneration in blood.
Journal: Nature communications
Published: August 06, 2021
Non-invasive molecular tracking method that measures ocular drug distribution in non-human primates.
Non-invasive molecular tracking method that measures ocular drug distribution in non-human primates.
Journal: Communications biology
Published: March 04, 2019
Using Healthcare Databases to Refine Understanding of Exploratory Associations Between Drugs and Progression of Open-Angle Glaucoma.
Journal: Clinical pharmacology and therapeutics
Published: January 14, 2019
Glaucoma - Next Generation Therapeutics: Impossible to Possible.
Journal: Pharmaceutical research
Published: October 20, 2018
Last Updated: 09/26/2026